{
    "title": "AstraZeneca's COVID-19 vaccine candidate begins late-stage U.S. study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8683395/AstraZenecas-COVID-19-vaccine-candidate-begins-late-stage-U-S-study.html",
    "date": "2020-08-31",
    "keywords": [
        "vaccine",
        "trial",
        "latestage",
        "study",
        "emergency",
        "plc",
        "monday",
        "profile",
        "covid19",
        "placebo",
        "company",
        "operation",
        "speed",
        "program",
        "development",
        "manufacturing",
        "distribution",
        "president",
        "donald",
        "trump",
        "coronavirus",
        "election",
        "astrazeneca",
        "conjunction",
        "university",
        "pfizer",
        "inc",
        "partner",
        "biontech",
        "se",
        "october",
        "use",
        "authorization",
        "approval",
        "azd1222",
        "britain",
        "brazil",
        "africa",
        "japan",
        "aim",
        "infection",
        "illness",
        "institutes",
        "health",
        "statement",
        "incidence",
        "department",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}